Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Heron Therapeutics
Pharma
FDA signs off on Aponovie for postoperative nausea and vomiting
The FDA approved Heron Therapeutics' Aponvie, which becomes the first intravenous NK antagonist available for postoperative nausea and vomiting.
Kevin Dunleavy
Sep 19, 2022 10:00am
Heron's Zynrelef hits a rough patch in Q4 as trajectory wobbles
Mar 3, 2022 7:40am
Heron's Zynrelef could hit blockbuster heights, analysts predict
May 14, 2021 11:13am
Heron's post-surgery pain med has won a long-awaited FDA nod
May 13, 2021 10:11am
